<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>8027447</pmcid><all-ids><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmid">33219313</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="pmc">8027447</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="publisher-id">906</article-id><article-id xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" pub-id-type="doi">10.1038/s41386-020-00906-2</article-id></all-ids><extracted-table><table-id>Tab1</table-id><table-label>Table 1</table-label><table-caption>Alterations in within-network functional connectivity (FC) in this work qualitatively compared with studies on other serotonergic, dopaminergic, and norepinephrinergic drugs.</table-caption><original-table><table-wrap xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table 1</label><caption><p>Alterations in within-network functional connectivity (FC) in this work qualitatively compared with studies on other serotonergic, dopaminergic, and norepinephrinergic drugs.</p></caption><table frame="hsides" rules="groups"><tbody><tr><td colspan="2"><inline-graphic xlink:href="41386_2020_906_Tab1_HTML.gif" id="d32e1013"/></td></tr></tbody></table><table-wrap-foot><p>Blue cells indicate decreases and red cells indicate increases in within-network FC. Gray cells indicate no alterations, black cells indicate that the network was not investigated. Impacts on neurotransmitter systems are shown using the same color scheme. This table refers to results in [<xref ref-type="bibr" rid="CR4">4</xref>–<xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR44">44</xref>–<xref ref-type="bibr" rid="CR52">52</xref>] and findings in this study.</p><p><sup>a</sup>Result was no longer significant after adjustment for potential confounds. 5-HT: serotonin, dopa: dopamine, NA: noradrenaline, L-dopa: levodopa, TRP: tryptophan.</p><p><sup>b</sup>Increased FC was reported in a small cluster at the borderline of the network.</p></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Alterations in within-network functional connectivity (FC) in this work qualitatively compared with studies on other serotonergic, dopaminergic, and norepinephrinergic drugs.</div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><tbody><tr><td colspan="2"/></tr></tbody></table></div>Blue cells indicate decreases and red cells indicate increases in within-network FC. Gray cells indicate no alterations, black cells indicate that the network was not investigated. Impacts on neurotransmitter systems are shown using the same color scheme. This table refers to results in [???–???, ???–???] and findings in this study.aResult was no longer significant after adjustment for potential confounds. 5-HT: serotonin, dopa: dopamine, NA: noradrenaline, L-dopa: levodopa, TRP: tryptophan.bIncreased FC was reported in a small cluster at the borderline of the network.</transformed-table></extracted-table></extracted-tables-set>